Storia in 2 fonti

Zydus secures U.S. FDA nod for scurvy injection generic

Zydus Lifesciences gains U.S. FDA approval for generic Ascorbic Acid Injection, used for treating scurvy, enhancing market competition.

Raccontata da

economictimes.indiatimes.com

thehindu.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindu.comStai leggendo1 g fa

Zydus secures U.S. FDA nod for scurvy injection generic

Zydus Lifesciences gains U.S. FDA approval for generic Ascorbic Acid Injection, used for treating scurvy, enhancing market competition.

originale

economictimes.indiatimes.com1 g fa

Zydus Lifesciences gets USFDA nod for generic ascorbic acid injection

Zydus Lifesciences secured final USFDA approval for its generic ascorbic acid injection. This approval is for the treatment of scurvy in specific patient groups. The company's product is the generic equivalent of the…

Leggi questa versione → originale

Timeline cronologica

venerdì 21 agosto 2026·economictimes.indiatimes.com
Zydus Lifesciences gets USFDA nod for generic ascorbic acid injection
Zydus Lifesciences secured final USFDA approval for its generic ascorbic acid injection. This approval is for the treatment of scurvy in specific patient groups. The company's…
venerdì 21 agosto 2026·thehindu.com
Zydus secures U.S. FDA nod for scurvy injection generic
Zydus Lifesciences gains U.S. FDA approval for generic Ascorbic Acid Injection, used for treating scurvy, enhancing market competition.